P942: DREAMM-9: PHASE I STUDY OF BELANTAMAB MAFODOTIN PLUS STANDARD OF CARE IN PATIENTS WITH TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA

• S. Z. Usmani,
• M. Mielnik,
• Y. Koh,
• A. Alonso Alonso,
• X. Leleu,
• H. Quach,
• C.-K. Min,
• W. Janowski,
• A.-O. Abdallah,
• M. Garg,
• I. Sandhu,
• E. M. Ocio San Miguel,
• A. Oriol,
• P. Rodriquez-Otero,
• K. Ramasamy,
• K. Weisel,
• B. Besemer,
• M. Cavo,
• X. L. Zhou,
• M. C. Kaisermann,
• C. M. Bego Marques,
• D. Williams,
• F. Carreno,
• B. E. Kremer,
• I. V. Gupta,
• M. Hus

Affiliations

S. Z. Usmani

1 Memorial Sloan Kettering Cancer Center, New York, NY, United States of America

M. Mielnik

2 Department of Hematooncology and Bone Marrow Transplantation, Medical University of Lublin, Lublin, Poland

Y. Koh

3 Seoul National University Hospital, Seoul, South Korea

A. Alonso Alonso

4 University Hospital Quirón Madrid, Madrid, Spain

X. Leleu

5 CHU de Poitiers, Poitiers, France

H. Quach

6 St.Vincent’s Hospital Melbourne, Melbourne, Australia

C.-K. Min

7 Catholic University of Korea Seoul St. Mary’s Hospital, Seoul, South Korea

W. Janowski

8 Calvary Mater Newcastle, Newcastle, Australia

A.-O. Abdallah

9 University of Kansas, Kansas City, KS, United States of America

M. Garg

10 Leicester Royal Infirmary, Leicester, United Kingdom

I. Sandhu

11 University of Alberta, Edmonton, Canada

E. M. Ocio San Miguel

12 Hospital Universitario Marqués de Valdecilla (IDIVAL), Universidad de Cantabria, Santander

A. Oriol

13 Institut Català d’Oncologia and Institut Josep Carreras - Hospital Universitari Germans Trias i Pujol (HUGTP), Badalona

P. Rodriquez-Otero

14 Department of Hematology, Clínica Universidad de Navarra, Pamplona, Spain

K. Ramasamy

15 Churchill Hospital, Headington, Oxford, United Kingdom

K. Weisel

16 University Medical Center Hamburg-Eppendorf, Hamburg

B. Besemer

17 University of Tübingen, Tübingen, Germany

M. Cavo

18 IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istitutodi Ematologia “Seràgnoli”, Universitàdegli Studi di Bologna, Bolonga, Italy

X. L. Zhou

19 GlaxoSmithkline, Waltham, MA

M. C. Kaisermann

20 GlaxoSmithKline, Upper Providence, PA, United States of America

C. M. Bego Marques

21 GlaxoSmithKline, Barcelona, Spain

D. Williams

20 GlaxoSmithKline, Upper Providence, PA, United States of America

F. Carreno

20 GlaxoSmithKline, Upper Providence, PA, United States of America

B. E. Kremer

20 GlaxoSmithKline, Upper Providence, PA, United States of America

I. V. Gupta

20 GlaxoSmithKline, Upper Providence, PA, United States of America

M. Hus

2 Department of Hematooncology and Bone Marrow Transplantation, Medical University of Lublin, Lublin, Poland